​

Funding Round

Series D - ARS Pharmaceuticals

Series D - ARS Pharmaceuticals

Investment Firm

Overview

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

Announced Date

Aug 31, 2021

Funding Type

Series D

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

SR One

SR One

SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorRA Capital Management
Participant InvestorSR One
Participant InvestorDeerfield

Round Details and Background

ARS Pharmaceuticals raised $55000000 on 2021-08-31 in Series D

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 14, 2018
Series C - ARS Pharmaceuticals
1-20.0M
Aug 31, 2021
Series D - ARS Pharmaceuticals
3-55.0M

Recent Activity

There is no recent news or activity for this profile.